TIRZEPATIDE Tirzepatide is a dual-action peptide that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, offering advanced metabolic and weight management support.
Regulates blood sugar levels, insulin sensitivity, and appetite by enhancing glucose-dependent insulin secretion and promoting satiety.
Suppresses glucagon secretion, delayed gastric emptying, and excessive food intake, supporting sustainable weight reduction and metabolic balance.
Effective in managing type 2 diabetes, pre-diabetes, and obesity, with superior weight loss outcomes compared to GLP-1 monotherapy.
May improve body composition, cardiometabolic health, hemoglobin A1c levels, and overall energy regulation when combined with lifestyle interventions.
Longevity Medical Institute
24
Made with FlippingBook Ebook Creator